Artios Pharma develops cancer treatments that target DNA damage response (DDR) pathways to kill cancer cells selectively
Kirsty Mackay
Director of Clinical Development
http://www.linkedin.com/in/kirstymackay
Hakan Goker
Board Member
https://nl.linkedin.com/in/hakan-goker-a61a674
Graeme Smith
Chief Scientific Officer
https://www.linkedin.com/in/graeme-smith-9b55b09/
Peter Harris
Development Consultant
https://www.linkedin.com/in/peter-harris-106b1514
Andrew Muncey
COO
https://www.linkedin.com/in/andrew-muncey-b7457b22